Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer

William L. Dahut, Ravi A. Madan, Joyson J. Karakunnel, David Adelberg, James L. Gulley, Ismail B. Turkbey, Cindy H. Chau, Shawn D. Spencer, Marcia Mulquin, John Wright, Howard L. Parnes, Seth M. Steinberg, Peter L. Choyke, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences